|
1
|
Vici A, Castelli G, Francescangeli F, Cerio A, Pelosi E, Screnci M, Rossi S, Morsilli O, Felli N, Pasquini L, Truglio GI, De Angelis ML, D’Andrea V, Rossi R, Verachi P, Vila F, Marziali G, Giuliani A, Zeuner A. Network Analysis of miRNA and Cytokine Landscape in Human Hematopoiesis. Int J Mol Sci 2024; 25:12305. [PMID: 39596371 PMCID: PMC11595288 DOI: 10.3390/ijms252212305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2024] [Revised: 11/13/2024] [Accepted: 11/13/2024] [Indexed: 11/28/2024] Open
Abstract
The differentiation/maturation trajectories of different blood cell types stemming from a CD34+ common ancestor takes place in different biologically relevant multidimensional spaces. Here, we generated microRNA and cytokine profiles from highly purified populations of hematopoietic progenitors/precursors derived from cord blood hematopoietic stem/progenitor cells. MicroRNA and cytokine landscapes were then analyzed to find their mutual relationships under the hypothesis that the highly variable miRNome corresponds to the 'force field' driving the goal of a stable phenotype (here corresponding to the cytokine abundance pattern) typical of each cell kind. The high dimensionality and lack of linearity of the hematopoietic process pushed us to adopt a distance-geometry approach to compare different trajectories, while a complex network analysis was instrumental in revealing the fine structure of microRNA-cytokine relations. Importantly, the approach enabled us to identify a limited number of factors (represented either by microRNAs or cytokines) corresponding to crucial nodes responsible for connecting distinct interaction modules. Subtle changes in 'master nodes', keeping the connections between different regulatory networks, may therefore be crucial in influencing hematopoietic differentiation. These findings highlight the extremely interconnected network structures underlying hematopoiesis regulation and identify key factors in the microRNA/cytokine landscape that may be potentially crucial for influencing network stability.
Collapse
Affiliation(s)
- Alessandro Vici
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy; (A.V.); (G.C.); (F.F.); (A.C.); (E.P.); (S.R.); (N.F.); (M.L.D.A.); (R.R.); (P.V.); (F.V.); (G.M.)
| | - Germana Castelli
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy; (A.V.); (G.C.); (F.F.); (A.C.); (E.P.); (S.R.); (N.F.); (M.L.D.A.); (R.R.); (P.V.); (F.V.); (G.M.)
| | - Federica Francescangeli
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy; (A.V.); (G.C.); (F.F.); (A.C.); (E.P.); (S.R.); (N.F.); (M.L.D.A.); (R.R.); (P.V.); (F.V.); (G.M.)
| | - Annamaria Cerio
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy; (A.V.); (G.C.); (F.F.); (A.C.); (E.P.); (S.R.); (N.F.); (M.L.D.A.); (R.R.); (P.V.); (F.V.); (G.M.)
| | - Elvira Pelosi
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy; (A.V.); (G.C.); (F.F.); (A.C.); (E.P.); (S.R.); (N.F.); (M.L.D.A.); (R.R.); (P.V.); (F.V.); (G.M.)
| | - Maria Screnci
- Banca Regionale Sangue Cordone Ombelicale, UOC Immunoematologia e Medicina Trasfusionale, Policlinico Umberto I, 00161 Rome, Italy;
| | - Stefania Rossi
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy; (A.V.); (G.C.); (F.F.); (A.C.); (E.P.); (S.R.); (N.F.); (M.L.D.A.); (R.R.); (P.V.); (F.V.); (G.M.)
| | - Ornella Morsilli
- Department of Cardiovascular, Endocrine-Metabolic Diseases and Ageing, Istituto Superiore di Sanità, 00161 Rome, Italy;
| | - Nadia Felli
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy; (A.V.); (G.C.); (F.F.); (A.C.); (E.P.); (S.R.); (N.F.); (M.L.D.A.); (R.R.); (P.V.); (F.V.); (G.M.)
| | - Luca Pasquini
- Core Facilities, Istituto Superiore di Sanità, 00161 Rome, Italy;
| | | | - Maria Laura De Angelis
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy; (A.V.); (G.C.); (F.F.); (A.C.); (E.P.); (S.R.); (N.F.); (M.L.D.A.); (R.R.); (P.V.); (F.V.); (G.M.)
| | - Vito D’Andrea
- Department of Surgery, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy;
| | - Rachele Rossi
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy; (A.V.); (G.C.); (F.F.); (A.C.); (E.P.); (S.R.); (N.F.); (M.L.D.A.); (R.R.); (P.V.); (F.V.); (G.M.)
| | - Paola Verachi
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy; (A.V.); (G.C.); (F.F.); (A.C.); (E.P.); (S.R.); (N.F.); (M.L.D.A.); (R.R.); (P.V.); (F.V.); (G.M.)
| | - Frenki Vila
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy; (A.V.); (G.C.); (F.F.); (A.C.); (E.P.); (S.R.); (N.F.); (M.L.D.A.); (R.R.); (P.V.); (F.V.); (G.M.)
- Department of Surgery, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy;
| | - Giovanna Marziali
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy; (A.V.); (G.C.); (F.F.); (A.C.); (E.P.); (S.R.); (N.F.); (M.L.D.A.); (R.R.); (P.V.); (F.V.); (G.M.)
| | - Alessandro Giuliani
- Environment and Health Department, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
| | - Ann Zeuner
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy; (A.V.); (G.C.); (F.F.); (A.C.); (E.P.); (S.R.); (N.F.); (M.L.D.A.); (R.R.); (P.V.); (F.V.); (G.M.)
| |
Collapse
|
|
2
|
Zhou H, Yao J, Zhong Z, Wei H, He Y, Li W, Hu K. Lactate-Induced CCL8 in Tumor-Associated Macrophages Accelerates the Progression of Colorectal Cancer through the CCL8/CCR5/mTORC1 Axis. Cancers (Basel) 2023; 15:5795. [PMID: 38136340 PMCID: PMC10741879 DOI: 10.3390/cancers15245795] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2023] [Revised: 11/28/2023] [Accepted: 12/07/2023] [Indexed: 12/24/2023] Open
Abstract
Tumor-associated macrophages (TAMs) play a pivotal role in shaping the tumor microenvironment. Lactic acid (LA) has been identified as an influential factor in promoting immune escape and tumor progression. However, the mechanisms through which LA modulates TAMs in colorectal cancer (CRC) remain poorly understood. We used qRT-PCR to quantify the expression of LA-related genes (LDHA and LAMP2) in CRC tumor tissues and adjacent nontumor tissues (n = 64). The biological effects and mechanisms of LA on macrophages and tumors were evaluated via qRT-PCR, Western blot, RNA-seq, wound healing assay, colony formation assay in vitro, and allograft mouse tumor models in vivo. We found the expression of LDHA and LAMP2 was highly elevated in the tumor regions and positively associated with a poor clinical stage of CRC. A high concentration of LA was generated under hypoxia; it could promote tumor progression and metastasis with the involvement of macrophages. The inhibition of LA release impaired this protumor phenomenon. Mechanically, LA induced M2 macrophages through the AKT/ERK signaling pathway; subsequently, M2 macrophages secreted CCL8 and facilitated the proliferation and metastasis of CRC cells by activating the CCL8/CCR5/mTORC1 axis. This effect was inhibited by the antagonist or knockdown of CCR5. In conclusion, lactate-induced CCL8 in TAMs accelerated CRC proliferation and metastasis through the CCL8/CCR5/mTORC1 axis.
Collapse
Affiliation(s)
- Hui Zhou
- Digestive Diseases Center, The Seventh Affiliated Hospital, Sun Yat-sen University, No. 628 Zhenyuan Road, Shenzhen 518107, China; (H.Z.); (Y.H.)
| | - Jiayi Yao
- Center of Excellence, The Seventh Affiliated Hospital of Sun Yat-sen University, No. 628 Zhenyuan Road, Shenzhen 518107, China;
| | - Zhaozhong Zhong
- Department of Kidney Transplantation, The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou 510630, China;
| | - Hongfa Wei
- Department of General Surgery, The First Affiliated Hospital of Shantou University Medical College, Jinping District, Shantou 515041, China;
| | - Yulong He
- Digestive Diseases Center, The Seventh Affiliated Hospital, Sun Yat-sen University, No. 628 Zhenyuan Road, Shenzhen 518107, China; (H.Z.); (Y.H.)
| | - Wenchao Li
- Department of General Surgery, The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou 510630, China
| | - Kunpeng Hu
- Department of General Surgery, The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou 510630, China
| |
Collapse
|